Conference to Discuss Antibiotic-Resistant Bacteria Responsible for Sarcoidosis and Other Autoimmune Diseases

[Guest guest]

Conference to Discuss Antibiotic-Resistant Bacteria Responsible for

Sarcoidosis and Other Autoimmune Diseases

Having demonstrated that antibiotic-resistant bacteria are the cause

of sarcoidosis, the Autoimmunity Research Foundation is bringing its

new-found knowledge to bear on other autoimmune diseases, AIDS and

cancers. Alan Cantwell Jr., M.D. will headline the foundation’s

conference June 17-18, 2006, discussing the role of cell-wall-

deficient bacteria in AIDS and cancer.

Thousand Oaks, CA (PRWEB) May 16, 2006 -- Having demonstrated that

antibiotic-resistant bacteria are the cause of sarcoidosis, the

Autoimmunity Research Foundation is bringing its new-found knowledge

to bear on other autoimmune diseases, AIDS and cancers. Alan Cantwell

Jr., M.D. will headline the foundation’s conference June 17-18, 2006,

discussing the role of cell-wall-deficient bacteria in AIDS and cancer.

In 1994, Dr. Cantwell’s book on AIDS, " Queer Blood, " won the

lin Book Award for literary excellence. There is probably no

other physician whose cancer and AIDS publications are so well known

-- and so controversial. Dr. Cantwell’s work supports the concept

that several ailments considered to be “autoimmune disease” may in

reality be chronic infections not easily detected by standard

laboratory testing techniques.

Trevor Marshall, Ph.D., will explain how hidden bacteria cause

disease as well as how to select antibiotics capable of treating

chronic diseases including sarcoidosis, rheumatoid arthritis,

thyroiditis, chronic fatigue syndrome and fibromyalgia.

Dr. Marshall’s recent papers have shown how modern molecular genomics

have produced a more complete understanding of the way these diseases

develop and how they can be effectively treated. His conference

presentation will address the issue of antibiotic resistance as well

as molecular genomics in the pathogenesis of chronic immune diseases.

The Autoimmunity Research Foundation is a non-profit organization.

The foundation successfully sponsored an application to the FDA

resulting in the designation of orphan-drug status for the common

antibiotic minocycline for use in treating sarcoidosis. “FDA

designation of orphan drug status for minocycline is a huge

breakthrough, but it’s only one part of our successful intervention,”

said Dr. Marshall. “This treatment is based on a detailed knowledge

of the bacterial pathogenesis and is aimed at treating the cause of

disease rather than simply controlling symptoms.”

The conference “Recovering from Chronic Disease,” sponsored by the

Autoimmunity Research Foundation, is designed for patients as well as

medical professionals. It will be held June 17-18, 2006 at the Los

Angeles Airport Hilton. The conference fee is $95 for registration

before May 22 and $115 thereafter. Registration may be completed

online at the foundation’s website: Online Registration LAX. Detailed

information on registration, speakers and times is online at: June

17-18 LAX Conference Brochure.

http://www.prweb.com/releases/2006/5/prweb386028.htm